The plummeting cost of genome sequencing may likely spur a jump in healthcare spending, Forbes contributor Peter Ubel says, and he thinks that maybe something ought to be done about that.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Cost of the Personal

Genomic Dawn

To Tell?

Human Knockouts

Following the Curve

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.